223 — Elife Holdings Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Elife Holdings, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -28.9 | -44.9 | -25.2 | -23.8 | -53.9 |
| Depreciation | |||||
| Non-Cash Items | 9.55 | 25.3 | 2.3 | 27 | 35.2 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.91 | 1.5 | 3.68 | -34.2 | -16.2 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -10.9 | -14.7 | -16.4 | -28.9 | -32.9 |
| Capital Expenditures | -0.106 | 0 | -0.042 | -0.002 | -0.22 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.371 | 5.85 | 0.001 | 0.004 | 0.284 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.265 | 5.85 | -0.041 | 0.002 | 0.064 |
| Financing Cash Flow Items | 0.212 | -0.014 | 2.19 | -4.84 | -0.054 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 8.21 | 5.07 | 8.02 | 54.3 | 25.8 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.61 | -3.78 | -8.52 | 24.9 | -8.59 |